Skip to main content

Table 1 Table

From: The incidence of serious bleeding events in a global, single-arm, open-label trial of Drotrecogin alfa (activated) in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS

 

PROWESS: placebo

PROWESS: DrotAA

ENHANCE: DrotAA

Total n

840

850

2378

During infusion

   

   Serious bleed

1.0 (n = 8)

2.4 (n = 20)

3.6 (n = 85)

   Fatal event

0.1 (n = 1)

0.5 (n = 4)

0.5 (n = 11)

Postinfusion

   

   Serious bleed

1.1 (n = 9)

1.2 (n = 10)

2.9 (n = 70)

  1. Values are shown as rates (%) unless otherwise indicated.
Back to article page

Critical Care

ISSN: 1364-8535